Skip to content

FAQ

Can biopesticides match the efficacy of synthetic pesticides?+

Modern biopesticides achieve comparable efficacy for many target pests and diseases, especially when applied as part of an integrated pest management program. Formulation quality and adjuvant selection are the critical differentiators.

Biopesticides typically follow a streamlined registration pathway compared to synthetic chemicals. ICAMA, EPA and EU regulations each have reduced data requirements for microbial and botanical active ingredients. Our regulatory team guides the process from dossier preparation to certificate.

Sample batches start at 1–4 tons for formulation validation. Pilot production runs at 5 tons for market testing. Standard volume production runs at 20+ tons per batch. Private-label co-branding on proven biopesticide platforms starts from lower quantities.

We use cold-flow production for temperature-sensitive strains, validated shelf-life testing under recommended storage, and per-batch CFU counts at manufacture and through the stability period. Cold-chain shipping options are available for microbial concentrates.

Suspension Concentrates (SC) are the standard for microbial actives, preserving spore viability and uniform dispersion. Water-Dispersible Granules (WDG) and Wettable Powders (WP) suit spore-based and botanical powders, while Emulsifiable Concentrates (EC) and Oil Dispersions (OD) are preferred for botanical oil actives such as neem and pyrethrin.

Yes. Many programmes position biopesticides as the backbone of an IPM strategy with synthetic products used only at thresholds. We can formulate compatible tank-mix partners and advise on timing so the biological and chemical components work together without degrading viability.

For heat-sensitive microbial concentrates we can supply cold-chain shipping, insulated packaging and cold-storage validation. For ambient-stable formulations we provide documented stability confirming viability at normal warehouse temperatures.

Many microbial and botanical actives are permitted in organic and low-input programmes. We can tailor the formulation, inert ingredients and documentation to support the certification standard in your target market, whether OMRI, EU organic or another scheme.

Each batch is released against CFU/g or titre specifications, germination rate for fungal actives, and purity checks, with a certificate of analysis supplied per shipment. We maintain full batch traceability and retain samples through the shelf-life period.

We provide strain identification, pathogenicity/toxicity and non-target organism studies, efficacy trial data and the analytical package for your active and formulation. Our regulatory team tailors the dossier to reduced-risk or accelerated pathways in your market.